Please provide your email address to receive an email when new articles are posted on . All hybrid closed-loop systems improved time in range and time below range compared with other insulin therapies ...

Heads of the FDA’s Center for Devices and Radiological Health (CDRH) recently penned a blog post describing their previous and ongoing efforts with closed-loop artificial pancreas manufacturers to ...

Medtrum’s latest advances center on its ultra-compact tubeless insulin pumps. The 200U configuration measures just 40.5 × 31.5 × 11.5 mm and weighs only 13.8 grams, making it the smallest and lightest ...

While insulin pumps and continuous glucose monitors have improved the lives of many Type 1 diabetes patients, some still cannot maintain steady control. Implantable insulin pumps offer another option ...

People with type 1 diabetes require continuous insulin treatment and must regularly measure their glucose levels. With open-loop therapies, insulin administration is manually controlled, while hybrid ...

Milpitas, California-based diabetes management device maker Bigfoot Biomedical has raised $37 million in Series B funding in a round co-led by funds from Janus Henderson Investors and Quadrant Capital ...

Two manufacturers of automated insulin delivery (AID) systems, Tandem Diabetes Care and Beta Bionics, have updated their products to integrate with the Dexcom G7 continuous glucose monitoring (CGM) ...

A century ago, type 1 diabetes was a death sentence. Children diagnosed rarely survived more than a year or two, wasting away as their bodies starved despite food. Then, in 1921, in a modest lab in ...

The US Food and Drug Administration has cleared new decision-support software that aids in insulin dosing. In addition, Insulin Algorithms is "an affordable, easily adoptable tool for every-size ...

The children's author said she was advised by her hospital diabetes team to be on the closed loop system for three months ...